ETF Lab / Live ETF Analysis

XLV - Health Care Sector ETF Analysis

XLV tracks large US health care companies across pharmaceuticals, biotech, equipment, and managed care. It gives traders a defensive-growth sector benchmark with different leadership behavior than technology or cyclicals.

Use this XLV analysis page to monitor live technical signals and evaluate whether health care is acting as a defensive leader or lagging the broader market.

View full interactive analysis →Open ETF dashboard

Current Price

$188.85

Daily change 0.54%

Momentum Score

9/10

Strong momentum

Daily Signal

BUY

Alignment score 3/3

Structural Score

5

BUY

Multi-Timeframe Signals

4H, Daily, Weekly, and Monthly readout for XLV

Structural interpretation: BUY

4H

NEUTRAL

$188.30

RSI
52.8
MACD
0.69
ATR
1.59
Updated
2026-11-13

Daily

BUY

$188.85

RSI
66.8
MACD
4.06
ATR
3.32
Updated
2026-11-13

Weekly

BUY

$188.85

RSI
73.8
MACD
8.04
ATR
6.35
Updated
2026-11-13

Monthly

BUY

$188.85

RSI
72.3
MACD
10.96
ATR
10.49
Updated
2026-11-13

Structural Analysis Composite Score

5 / 100

ETF Lab scores key levels, candlestick behavior, chart patterns, and divergences to create a single structural analysis reading for XLV. The current interpretation is BUY.

Key levels1.5
Candlestick0
Chart patterns2.6
Divergences1

Why Traders Watch XLV

Technical context, not just headline price

XLV tracks large US health care companies across pharmaceuticals, biotech, equipment, and managed care. It gives traders a defensive-growth sector benchmark with different leadership behavior than technology or cyclicals.

Use this XLV analysis page to monitor live technical signals and evaluate whether health care is acting as a defensive leader or lagging the broader market.

Interactive Follow-Through

Move from this static SEO page into the live dashboard to inspect history, screen the full ETF universe, and compare XLV against other high-liquidity funds with the same technical model.

View full interactive analysis →